nsv6314523
- Organism: Homo sapiens
- Study:nstd102 (Clinical Structural Variants)
- Variant Type:complex chromosomal rearrangement
- Method Type:Multiple
- Submitted on:GRCh37
- Variant Calls:3
- Validation:Not tested
- Clinical Assertions: Yes
- Region Size:1
- Description:46;XYt(2;5)(q22;q22)dn AND multiple conditions
- Publication(s):Manickam et al. 2021, Michelson et al. 2011, Redin et al. 2016
- Genome View
- Variant Region Details and Evidence
- Validation Information
- Clinical Assertions
- Genotype Information
Genome View
Select assembly:Overlapping variant regions from other studies: 145 SVs from 27 studies. See in: genome view
Overlapping variant regions from other studies: 138 SVs from 26 studies. See in: genome view
Overlapping variant regions from other studies: 121 SVs from 29 studies. See in: genome view
Overlapping variant regions from other studies: 121 SVs from 29 studies. See in: genome view
Overlapping variant regions from other studies: 121 SVs from 29 studies. See in: genome view
Overlapping variant regions from other studies: 121 SVs from 29 studies. See in: genome view
Overlapping variant regions from other studies: 145 SVs from 27 studies. See in: genome view
Overlapping variant regions from other studies: 138 SVs from 26 studies. See in: genome view
Overlapping variant regions from other studies: 121 SVs from 29 studies. See in: genome view
Overlapping variant regions from other studies: 121 SVs from 29 studies. See in: genome view
Overlapping variant regions from other studies: 121 SVs from 29 studies. See in: genome view
Overlapping variant regions from other studies: 121 SVs from 29 studies. See in: genome view
Variant Region Placement Information
Variant Region ID | Placement Type | Score | Assembly | Assembly Unit | Reciprocity | Sequence ID | Chr | Start | Stop | strand |
---|---|---|---|---|---|---|---|---|---|---|
nsv6314523 | Remapped | Perfect | GRCh38.p12 | Primary Assembly | First Pass | NC_000002.12 | Chr2 | 148,258,393 | 148,258,393 | + |
nsv6314523 | Remapped | Perfect | GRCh38.p12 | Primary Assembly | First Pass | NC_000002.12 | Chr2 | 148,259,189 | 148,259,189 | + |
nsv6314523 | Remapped | Perfect | GRCh38.p12 | Primary Assembly | First Pass | NC_000005.10 | Chr5 | 120,150,269 | 120,150,269 | + |
nsv6314523 | Remapped | Perfect | GRCh38.p12 | Primary Assembly | First Pass | NC_000005.10 | Chr5 | 120,150,308 | 120,150,308 | - |
nsv6314523 | Remapped | Perfect | GRCh38.p12 | Primary Assembly | First Pass | NC_000005.10 | Chr5 | 120,150,477 | 120,150,477 | - |
nsv6314523 | Remapped | Perfect | GRCh38.p12 | Primary Assembly | First Pass | NC_000005.10 | Chr5 | 120,150,481 | 120,150,481 | + |
nsv6314523 | Submitted genomic | GRCh37 (hg19) | Primary Assembly | NC_000002.11 | Chr2 | 149,015,962 | 149,015,962 | + | ||
nsv6314523 | Submitted genomic | GRCh37 (hg19) | Primary Assembly | NC_000002.11 | Chr2 | 149,016,758 | 149,016,758 | + | ||
nsv6314523 | Submitted genomic | GRCh37 (hg19) | Primary Assembly | NC_000005.9 | Chr5 | 119,485,964 | 119,485,964 | + | ||
nsv6314523 | Submitted genomic | GRCh37 (hg19) | Primary Assembly | NC_000005.9 | Chr5 | 119,486,003 | 119,486,003 | - | ||
nsv6314523 | Submitted genomic | GRCh37 (hg19) | Primary Assembly | NC_000005.9 | Chr5 | 119,486,172 | 119,486,172 | - | ||
nsv6314523 | Submitted genomic | GRCh37 (hg19) | Primary Assembly | NC_000005.9 | Chr5 | 119,486,176 | 119,486,176 | + |
Variant Call Information
Variant Call ID | Type | Method | Analysis | Subject Phenotype | Clinical Interpretation | Source of Interpretation | ClinVar ID |
---|---|---|---|---|---|---|---|
nssv17975787 | interchromosomal translocation | Multiple | Multiple | Focal seizures; Focal-onset seizure; Global developmental delay; Global developmental delay | Pathogenic | ClinVar | RCV000258700.1, VCV000267895.1 |
nssv17975789 | interchromosomal translocation | Multiple | Multiple | Focal seizures; Focal-onset seizure; Global developmental delay; Global developmental delay | Pathogenic | ClinVar | RCV000258700.1, VCV000267895.1 |
nssv17975788 | intrachromosomal translocation | Multiple | Multiple | Focal seizures; Focal-onset seizure; Global developmental delay; Global developmental delay | Pathogenic | ClinVar | RCV000258700.1, VCV000267895.1 |
Variant Call Placement Information
Variant Call ID | Placement Type | Score | Assembly | Reciprocity | Sequence ID | Chr | Start | Stop | strand |
---|---|---|---|---|---|---|---|---|---|
nssv17975787 | Remapped | Perfect | GRCh38.p12 | First Pass | NC_000002.12 | Chr2 | 148,258,393 | 148,258,393 | + |
nssv17975789 | Remapped | Perfect | GRCh38.p12 | First Pass | NC_000002.12 | Chr2 | 148,259,189 | 148,259,189 | + |
nssv17975789 | Remapped | Perfect | GRCh38.p12 | First Pass | NC_000005.10 | Chr5 | 120,150,269 | 120,150,269 | + |
nssv17975788 | Remapped | Perfect | GRCh38.p12 | First Pass | NC_000005.10 | Chr5 | 120,150,308 | 120,150,308 | - |
nssv17975787 | Remapped | Perfect | GRCh38.p12 | First Pass | NC_000005.10 | Chr5 | 120,150,477 | 120,150,477 | - |
nssv17975788 | Remapped | Perfect | GRCh38.p12 | First Pass | NC_000005.10 | Chr5 | 120,150,481 | 120,150,481 | + |
nssv17975787 | Submitted genomic | GRCh37 (hg19) | NC_000002.11 | Chr2 | 149,015,962 | 149,015,962 | + | ||
nssv17975789 | Submitted genomic | GRCh37 (hg19) | NC_000002.11 | Chr2 | 149,016,758 | 149,016,758 | + | ||
nssv17975789 | Submitted genomic | GRCh37 (hg19) | NC_000005.9 | Chr5 | 119,485,964 | 119,485,964 | + | ||
nssv17975788 | Submitted genomic | GRCh37 (hg19) | NC_000005.9 | Chr5 | 119,486,003 | 119,486,003 | - | ||
nssv17975787 | Submitted genomic | GRCh37 (hg19) | NC_000005.9 | Chr5 | 119,486,172 | 119,486,172 | - | ||
nssv17975788 | Submitted genomic | GRCh37 (hg19) | NC_000005.9 | Chr5 | 119,486,176 | 119,486,176 | + |
No validation data were submitted for this variant
Clinical Assertions
Variant Call ID | Type | Allele Origin | Subject Phenotype | Clinical Interpretation | Source of Interpretation | ClinVar ID |
---|---|---|---|---|---|---|
nssv17975787 | interchromosomal translocation | de novo | Focal seizures; Focal-onset seizure; Global developmental delay; Global developmental delay | Pathogenic | ClinVar | RCV000258700.1, VCV000267895.1 |
nssv17975789 | interchromosomal translocation | de novo | Focal seizures; Focal-onset seizure; Global developmental delay; Global developmental delay | Pathogenic | ClinVar | RCV000258700.1, VCV000267895.1 |
nssv17975788 | intrachromosomal translocation | de novo | Focal seizures; Focal-onset seizure; Global developmental delay; Global developmental delay | Pathogenic | ClinVar | RCV000258700.1, VCV000267895.1 |